V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Health Care

Biotechnology

V-Wave

Neal Eigler

Jessica Marie Davis

Arek Dobkowski

Lydia Telep

Werner Hafelfinger

Debbie Deutsch

Lior Rosen

Matt Borenzweig

William T. Abraham

William Hughes

Erez Rozenfeld

The Leadership Team at V-Wave is responsible for guiding the strategic vision and operational execution of the company as it develops innovative percutaneous implantable devices for Chronic Heart Failure. This cross-functional team, composed of executives from various departments, collaborates to ensure alignment on clinical development, regulatory compliance, financial management, and market readiness, ultimately aiming to enhance patient outcomes and drive the company’s growth in the cardiovascular device market.

Leadership Team

Clinical Operations

Finance and Accounting

Leadership Team

About

Team members

Other teams at V-Wave

Clinical Operations

Finance and Accounting